IPSEF - Ipsen S.A. Non-GAAP EPS of Euro9.15 revenue of Euro3.13B; initiates FY24 outlook
2024-02-08 01:14:21 ET
More on Ipsen:
- FDA grants priority review of Genfit-Ipsen liver disease drug
- Genfit stock rallies 20% after hours on data for liver disease drug
- Historical earnings data for Ipsen S.A.
- Dividend scorecard for Ipsen S.A.
- Financial information for Ipsen S.A.